Notice: This company has been marked as potentially delisted and may not be actively trading. Akers Biosciences (AKER) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrends AKER vs. CDIO, BMRA, TRIB, VRAX, AWH, TNFA, MYMD, NAVB, IDXX, and LNTHShould you be buying Akers Biosciences stock or one of its competitors? The main competitors of Akers Biosciences include Cardio Diagnostics (CDIO), Biomerica (BMRA), Trinity Biotech (TRIB), Virax Biolabs Group (VRAX), Aspira Women's Health (AWH), TNF Pharmaceuticals (TNFA), MyMD Pharmaceuticals (MYMD), Navidea Biopharmaceuticals (NAVB), IDEXX Laboratories (IDXX), and Lantheus (LNTH). These companies are all part of the "medical" sector. Akers Biosciences vs. Cardio Diagnostics Biomerica Trinity Biotech Virax Biolabs Group Aspira Women's Health TNF Pharmaceuticals MyMD Pharmaceuticals Navidea Biopharmaceuticals IDEXX Laboratories Lantheus Akers Biosciences (NASDAQ:AKER) and Cardio Diagnostics (NASDAQ:CDIO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, community ranking, profitability and risk. Does the MarketBeat Community favor AKER or CDIO? Akers Biosciences received 303 more outperform votes than Cardio Diagnostics when rated by MarketBeat users. However, 80.00% of users gave Cardio Diagnostics an outperform vote while only 72.92% of users gave Akers Biosciences an outperform vote. CompanyUnderperformOutperformAkers BiosciencesOutperform Votes30772.92% Underperform Votes11427.08% Cardio DiagnosticsOutperform Votes480.00% Underperform Votes120.00% Which has more risk & volatility, AKER or CDIO? Akers Biosciences has a beta of 0.3, indicating that its share price is 70% less volatile than the S&P 500. Comparatively, Cardio Diagnostics has a beta of 3.6, indicating that its share price is 260% more volatile than the S&P 500. Do institutionals & insiders believe in AKER or CDIO? 5.5% of Akers Biosciences shares are owned by institutional investors. Comparatively, 8.1% of Cardio Diagnostics shares are owned by institutional investors. 0.3% of Akers Biosciences shares are owned by company insiders. Comparatively, 22.3% of Cardio Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is AKER or CDIO more profitable? Akers Biosciences has a net margin of 0.00% compared to Cardio Diagnostics' net margin of -22,732.03%. Akers Biosciences' return on equity of -87.42% beat Cardio Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Akers BiosciencesN/A -87.42% -73.31% Cardio Diagnostics -22,732.03%-258.85%-191.20% Which has stronger valuation and earnings, AKER or CDIO? Akers Biosciences has higher revenue and earnings than Cardio Diagnostics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAkers Biosciences$1.58M5.05-$3.89MN/AN/ACardio Diagnostics$35.69K737.14-$8.38MN/AN/A Do analysts prefer AKER or CDIO? Cardio Diagnostics has a consensus price target of $2.00, suggesting a potential upside of 296.43%. Given Cardio Diagnostics' stronger consensus rating and higher possible upside, analysts clearly believe Cardio Diagnostics is more favorable than Akers Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Akers Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Cardio Diagnostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to AKER or CDIO? In the previous week, Akers Biosciences' average media sentiment score of 0.00 equaled Cardio Diagnostics'average media sentiment score. Company Overall Sentiment Akers Biosciences Neutral Cardio Diagnostics Neutral SummaryCardio Diagnostics beats Akers Biosciences on 8 of the 14 factors compared between the two stocks. Get Akers Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AKER and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AKER vs. The Competition Export to ExcelMetricAkers BiosciencesDiagnostic Substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.98M$2.30B$5.84B$9.14BDividend YieldN/A0.75%4.75%3.85%P/E RatioN/A5.5526.7019.17Price / Sales5.0562.84435.2970.71Price / CashN/A15.7538.0134.83Price / Book0.093.287.644.62Net Income-$3.89M-$65.73M$3.19B$246.06M Akers Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AKERAkers BiosciencesN/A$0.48-2.6%N/A-86.8%$7.98M$1.58M0.004CDIOCardio Diagnostics1.7916 of 5 stars$0.67-1.2%$2.00+198.8%-68.1%$27.07M$20,000.000.001Gap UpBMRABiomerica0.4742 of 5 stars$0.83+6.7%N/A-22.6%$15.22M$5.41M-2.4460Gap UpTRIBTrinity Biotech0.4033 of 5 stars$0.76flatN/AN/A$13.72M$56.83M-0.34480VRAXVirax Biolabs Group0.8374 of 5 stars$1.90+1.3%N/A+93.9%$6.15M$160,000.000.005AWHAspira Women's Health0.9131 of 5 stars$0.24-14.3%$4.40+1,733.3%-95.3%$4.00M$9.15M-0.20110Gap UpHigh Trading VolumeTNFATNF PharmaceuticalsN/A$0.57+0.5%N/AN/A$1.57MN/A0.006Gap DownHigh Trading VolumeMYMDMyMD PharmaceuticalsN/A$0.57+0.5%N/A-85.2%$1.35MN/A0.006Gap DownHigh Trading VolumeNAVBNavidea BiopharmaceuticalsN/A$0.00+16.7%N/A-98.3%$70,000.00$8,126.000.0010Analyst ForecastGap UpIDXXIDEXX Laboratories4.5807 of 5 stars$444.53-3.3%$533.75+20.1%-18.4%$36.40B$3.90B41.6611,000Positive NewsLNTHLantheus4.5698 of 5 stars$79.94-2.5%$131.86+64.9%+37.9%$5.56B$1.30B13.30700Analyst RevisionNews CoveragePositive News Related Companies and Tools Related Companies Cardio Diagnostics Alternatives Biomerica Alternatives Trinity Biotech Alternatives Virax Biolabs Group Alternatives Aspira Women's Health Alternatives TNF Pharmaceuticals Alternatives MyMD Pharmaceuticals Alternatives Navidea Biopharmaceuticals Alternatives IDEXX Laboratories Alternatives Lantheus Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AKER) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredCritical ‘Buy Now’ Alert on My Favorite Stock!My absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akers Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akers Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
